Clearing acne scars and post-inflammatory hyperpigmentation (PIH) requires a dual-track approach that addresses both textural changes and pigmentary irregularities. For PIH, which presents as flat brown or red marks, clinical evidence supports the use of tyrosinase inhibitors like azelaic acid, kojic acid, and alpha arbutin to regulate melanin production [1]. Niacinamide and retinoids further assist by inhibiting melanosome transfer and accelerating cellular turnover, effectively lifting existing pigment from the epidermal layers [2].
True acne scars—such as atrophic (pitted) or hypertrophic (raised) scars—involve structural damage to the dermal collagen matrix and cannot be fully resolved with topical creams alone. Management of these requires collagen-induction therapies such as microneedling, chemical peels, or fractional laser resurfacing to remodel the skin's architecture [3]. For optimal results, a consistent daily application of broad-spectrum SPF 50+ is mandatory, as ultraviolet radiation exacerbates pigmentation and degrades the collagen necessary for scar repair [4].
Post-inflammatory hyperpigmentation (PIH) is a reactive process where inflammatory mediators, such as prostaglandins and leukotrienes, stimulate melanocytes to increase melanin synthesis and distribution to surrounding keratinocytes [1]. This results in the characteristic discolouration seen after an acne lesion heals. The severity of PIH is often correlated with the depth of the initial inflammatory response and the patient's phototype, with darker skin tones being more prone to prolonged pigmentary changes [2].
In contrast, atrophic acne scarring is the result of an abnormal wound-healing response following a severe inflammatory acne episode. When the inflammatory process destroys the dermal fat and collagen, and the subsequent repair phase fails to replace the tissue adequately, a depression or 'pit' forms [3]. Modern dermatological interventions focus on controlled 'micro-insults' to the skin to trigger a secondary healing cascade, effectively reorganising the extracellular matrix and improving skin topography over several months [5].
---
For those looking to address the lingering shadows of dark spots, our C-Veil Citrine Tonic was formulated with Ascorbic Acid and Niacinamide to gently encourage a more radiant, even-toned complexion. You might also consider incorporating Solenne Oil into your evening ritual, as it utilises Bakuchiol to support natural cellular turnover and skin renewal without the irritation often associated with traditional retinoids.
FAQ
What is the difference between PIH and PIE?
Post-inflammatory hyperpigmentation (PIH) refers to brown or black marks caused by excess melanin, whereas post-inflammatory erythema (PIE) refers to red or pink marks caused by dilated capillaries near the skin surface [1]. While PIH responds well to brightening actives like Vitamin C, PIE often requires vascular lasers or soothing ingredients like tranexamic acid to constrict blood vessels and reduce redness [6].
Does Vitamin C help with acne scars?
Vitamin C (L-ascorbic acid) is highly effective for fading the pigmentary component of scars due to its ability to inhibit the tyrosinase enzyme [2]. Furthermore, it serves as a crucial cofactor for collagen synthesis, meaning it can support the skin's structural integrity when used alongside professional resurfacing treatments, though it will not 'fill' deep pits on its own [4].
Can retinoids fix deep pitted scars?
Prescription-strength retinoids or high-potency retinol can improve the appearance of shallow atrophic scars by stimulating epidermal thickness and collagen production over long-term use [3]. However, for deep ice-pick or boxcar scars, retinoids are generally considered a supportive therapy rather than a primary cure, with subcision or laser therapy providing more significant structural improvement [5].
References:
[1] Callender VD, et al. Journal of Clinical and Aesthetic Dermatology. 2017;10(7):18-23. doi:10.12788/j.sder.2017.031
[2] Desai SR. The Journal of Clinical and Aesthetic Dermatology. 2014;7(8):37-51.
[3] Fabbrocini G, et al. Dermatology Research and Practice. 2010;2010:893080. doi:10.1155/2010/893080
[4] Passeron T, et al. Journal of the European Academy of Dermatology and Venereology. 2019;33(S6):15-21. doi:10.1111/jdv.15951
[5] Connolly D, et al. The Journal of Clinical and Aesthetic Dermatology. 2017;10(9):12-23.
[6] Bae-Harboe YS, Graber EM. The Journal of Clinical and Aesthetic Dermatology. 2013;6(9):46-47.
Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any new skincare regimen. Content reviewed by a biomedical scientist.
